PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
2.13%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
-4.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
8.13%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-4.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.26%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4.26%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3141.T is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.14%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.82%
10Y revenue/share CAGR under 50% of 3141.T's 138.61%. Michael Burry would suspect a lasting competitive disadvantage.
-10.63%
Negative 5Y CAGR while 3141.T stands at 55.60%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
34.92%
3Y revenue/share CAGR 1.25-1.5x 3141.T's 30.27%. Bruce Berkowitz might see better product or regional expansions than the competitor.
100.00%
10Y OCF/share CAGR in line with 3141.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
189.89%
Net income/share CAGR at 50-75% of 3141.T's 291.58%. Martin Whitman might question if the firm’s product or cost base lags behind.
14.72%
Below 50% of 3141.T's 61.83%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
61.26%
3Y net income/share CAGR above 1.5x 3141.T's 14.65%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
132.27%
Equity/share CAGR of 132.27% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
27.36%
Below 50% of 3141.T's 114.25%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.35%
3Y equity/share CAGR above 1.5x 3141.T's 30.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.78%
Firm’s AR is declining while 3141.T shows 3.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.34%
Inventory is declining while 3141.T stands at 11.90%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.61%
Negative asset growth while 3141.T invests at 2.53%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.83%
BV/share growth above 1.5x 3141.T's 1.50%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.53%
SG&A declining or stable vs. 3141.T's 2.58%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.